CERTIFICATION REPORT The certification of anti-myeloperoxidase immunoglobulin G in human serum ERM® - DA476/IFCC
This report describes the production and certification of ERM-DA476/IFCC, a new serum protein reference material intended for the standardisation of measurements of anti-myeloperoxidase immunoglobulin G (anti-MPO IgG) antibodies. The material was produced according to ISO Guide 34:2009.
The raw material used to prepare ERM-DA476/IFCC was a plasmapheresis material containing a high concentration of anti-MPO IgG. After a thorough commutability study lyophilised serum was selected as the format for the candidate reference material. Serum processing was performed based on the procedure used for the reference material ERM-DA470k/IFCC. The plasma was converted into serum which was then delipidated. After the addition of preservatives the processed serum was diluted with plasmapheresis solution containing albumin, prior to the transfer of 1 mL aliquots to glass vials. The serum was then lyophilised and the vials closed with rubber stoppers and screw caps under nitrogen atmosphere prior to storage at -70 °C.
The between unit-homogeneity was quantified and stability during dispatch and storage were assessed in accordance with ISO Guide 35:2006.
The material was characterised by an inter-laboratory comparison exercise performed by laboratories of demonstrated competence and with adherence to ISO/IEC 17025 [5], using a purified anti-MPO IgG preparation as calibrant. This was achieved using a value transfer protocol previously used in the characterisation of ERM-DA470k/IFCC. Technically invalid results were removed. However no other outliers were eliminated on statistical grounds only.
Uncertainties of the certified values were calculated in accordance to the Guide to the Expression of Uncertainty in Measurement (GUM) and include uncertainties relating to possible lack of homogeneity, instability and characterisation.
The material is intended for the calibration of methods and quality control. As any reference material, it can also be used for control charts or validation studies. The CRM is available in glass vials containing the lyophilised residue of 1 g serum. The minimum amount of reconstituted sample to be used is 10 μL.
The CRM was accepted as European Reference Material (ERM®) after peer evaluation by the partners of the European Reference Materials consortium.
MONOGIOUDI Evanthia;
HUTU Dana Petronela;
MARTOS SEVILLA Gustavo;
TUDDENHAM Emma;
SHELDON Joanna;
SCHIMMEL Heinz;
TRAPMANN Stefanie;
MERONI Pierluigi;
EMONS Hendrik;
ZEGERS Ingrid;
2015-04-08
Publications Office of the European Union
JRC94458
978-92-79-45349-6,
1831-9424,
EUR 27092,
OP LA-NA-27092-EN-N,
https://publications.jrc.ec.europa.eu/repository/handle/JRC94458,
10.2787/798324,
Additional supporting files
| File name | Description | File type | |
|---|
